We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
21 hedge funds and large institutions have $92.8M invested in Fate Therapeutics in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
276% more capital invested
Capital invested by funds: $24.7M → $92.8M (+$68.2M)
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
31% more funds holding
Funds holding: 16 → 21 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
21
Holders Change
+5
Holders Change %
+31.25%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
4
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.6M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$1.94M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1M |
| 4 |
Bank of New York Mellon
New York
|
+$297K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$185K |
